LEGN 6-K: SEC filing

Filed with the SEC on · accession 0001801198-26-000026

LEGN filed a 6-K (foreign company report) with the SEC on Nov 10, 2026. How foreign companies listed in the US report news and events — like an 8-K for them.

Summary of the filing

Legend Biotech furnished its unaudited interim condensed consolidated financial statements and Management's Discussion and Analysis for the three and nine months ended September 30, 2026, along with a press release on its financial results and recent business highlights.

Key details

RegistrantLegend Biotech Corporation
License counterpartyNovartis
License counterpartyJanssen

✦ Ask GOAX AI about this filing — what it means for LEGN, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LEGN?

Click here

Frequently asked questions

What did LEGN file with the SEC on Nov 10, 2026?

LEGN filed a 6-K (SEC filing). Legend Biotech furnished its unaudited interim condensed consolidated financial statements and Management's Discussion and Analysis for the three and nine months ended September 30, 2026, along with a press release on its financial results and recent business highlights.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

Other LEGN SEC filings

Get alerts when LEGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days